XML 34 R25.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stock-Based Compensation (Tables)
 9 Months Ended
Oct. 29, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of Compensation Costs
The stock-based compensation costs that have been charged against income were as follows (in thousands):

13-Weeks Ended39-Weeks Ended
October 29,
2022		October 30,
2021		October 29,
2022		October 30,
2021
Stock-based compensation expense by type:
Stock options
$— $— $155 $174 
Restricted stock units1,269 1,126 4,881 4,005 
Employee stock purchases
69 47 304 156 
Director deferred compensation26 17 67 38 
  Total stock-based compensation expense1,364 1,190 5,407 4,373 
Income tax benefit recognized321 284 1,247 1,047 
  Stock-based compensation expense, net of income tax$1,043 $906 $4,160 $3,326 
Schedule of Equity Awards Granted
We granted the following equity awards:
13-Weeks Ended39-Weeks Ended
October 29,
2022		October 30,
2021		October 29,
2022		October 30,
2021
Stock options
— — 7,212 4,384 
Restricted stock unit awards
1,469 — 110,990 62,031 
Performance-based restricted stock unit awards
— — 49,978 22,492 
Deferred stock units
510 228 1,447 486 
Schedule of Shares Purchased
The number of shares purchased, the average price per share and the weighted-average grant date fair value of shares purchased through our employee stock purchase plan were as follows:
13-Weeks Ended39-Weeks Ended
October 29,
2022		October 30,
2021		October 29,
2022		October 30,
2021
Shares purchased6,408 2,495 28,033 12,003 
Average price per share$38.11 $65.11 $49.30 $47.95 
Weighted-average fair value at grant date$11.41 $22.22 $14.58 $13.68